Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Established in 2005, is a privately held company specialized in distributing and dispending diverse health care products, medical supplies. Since operating in a sector where human health is the primary essence, MT focused heavily in providing services designed at global standards considering all the dynamics of a sector focused on human health.
MT empowers customers by providing the broadest suite of products and services and deepest range of experience in healthcare. We bring together industry-leading distribution services, proper packaging, services to reduce costs and improve the quality of the sector.
The mission of MT is to maintain its well established position by analyzing the dynamics of the sector, maintain its reputation as a reliable organization providing quality distribution services as a point of access between pharmacies and suppliers, and provide for the needs, demands and expectations of its customers by offering the possible widest range of products with the most favorable commercial terms.
MT has approximately 80 employees, operates in 7 regions and 81 cities.MTHealthcare through its subsidiaries markets various healthcare products over 1500 items that save and sustain the lives of people with diabetic disorder, disc hernia , and other chronic and acute medical conditions. As a local and in some products global, diversified healthcare company, MT applies a unique combination of expertise in medical support devices, pharmaceuticals and biotechnology to create products that advance patient care nationwide.
As of underlining the major success story of MT is being the leader of Blood Glucose Monitoring Systems and consumables / test strips in Turkey ahead of worlds famous companies like ABBOTT , ROCHE , BAYER and JOHNSON&JOHNSON . Monthly sales percentage is around % 33 for strips of the total market.This data is based on IMS figures and calculations.
MT also exclusively distributes 2 patented medical device which are owned by the MT Holding. Such distinctive products and its segments are defined in below paragraphs as Disc Hernia “Back and Neck Ache” and Cranial Implant Systems.
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system sustainability. Potnis also highlights the strengths of Turkey’s healthcare…
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two countries under economic pressure and the advantages of Bayer’s longstanding relationship in both…
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s restructuring in the region and its desire to replicate its success in Turkey across…
The secretary general for Turkey’s Pharmaceutical Manufacturers Association (IEIS), Savaş Malkoç, highlights their objective of increasing R&D expenditure and Turkey’s big opportunity ahead in biosimilars production. In addition, Malkoç discusses…
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson & Johnson in different local, regional and global roles…
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular disease, which accounts for over a third of deaths in Turkey, the improvements made…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on Turkey as a future regional hub through deep investment in clinical trials,…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the improvements to the difference between a Ford Model T to a…
See our Cookie Privacy Policy Here
